Log In
Print
BCIQ
Print
Print this Print this
 

RG7652

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionMAb against proprotein convertase subtilisin/kexin type 9 (PCSK9)
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase II
IndicationMetabolic syndrome
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today